- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有41家主力机构披露2025-12-31报告期持股数据，持仓量总计1.63亿股，占流通A股11.47%
- 波段诊断：
-
技术面诊股
诊断结果：4.9技术面打败了47%的股票
技术面评分前10的股票
近期的平均成本为3.51元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为3.51元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"3.51","date":1780560798,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，跑输行业平均水平。
[{"date":"2026.06.05","stock":"0.00","trade":"0.25","ind":"-2.21"},{"date":"2026.06.04","stock":"-3.32","trade":"-1.80","ind":"-0.27"},{"date":"2026.06.03","stock":"0.00","trade":"-1.10","ind":"0.73"},{"date":"2026.06.02","stock":"-4.24","trade":"-2.06","ind":"1.63"},{"date":"2026.06.01","stock":"0.00","trade":"0.40","ind":"-1.51"},{"date":"2026.05.29","stock":"-3.83","trade":"0.36","ind":"-1.81"},{"date":"2026.05.28","stock":"-0.76","trade":"-0.71","ind":"0.80"},{"date":"2026.05.27","stock":"-3.89","trade":"-1.05","ind":"-0.88"},{"date":"2026.05.26","stock":"-4.64","trade":"-1.43","ind":"0.12"},{"date":"2026.05.25","stock":"-2.05","trade":"-1.35","ind":"1.66"},{"date":"2026.05.22","stock":"3.77","trade":"0.11","ind":"2.30"},{"date":"2026.05.21","stock":"-5.36","trade":"-1.67","ind":"-2.07"},{"date":"2026.05.20","stock":"1.36","trade":"-0.92","ind":"0.00"},{"date":"2026.05.19","stock":"-4.12","trade":"0.64","ind":"0.26"},{"date":"2026.05.18","stock":"1.32","trade":"-1.49","ind":"-0.20"},{"date":"2026.05.15","stock":"-1.09","trade":"-0.71","ind":"-1.17"},{"date":"2026.05.14","stock":"-3.16","trade":"-1.71","ind":"-2.14"},{"date":"2026.05.13","stock":"-1.86","trade":"-0.44","ind":"1.67"},{"date":"2026.05.12","stock":"7.08","trade":"-1.41","ind":"-0.47"},{"date":"2026.05.11","stock":"4.15","trade":"1.65","ind":"2.16"},{"date":"2026.05.08","stock":"-3.77","trade":"0.14","ind":"-0.50"}]
尔康制药,深证成指,化学制药指数
压力支撑
该股压力位为3.49元，支撑位为3.42元。
[{"text":"\u538b\u529b\u4f4d","value":"3.49","date":1780588800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"3.42","date":1780588800,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.1资金面打败了8%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：06月05日 20:30
| 机构今日流向(万元) | -847.58 | 机构5日流向(万元) | -5607.39 |
| 机构10日流向(万元) | -10248.54 | 机构20日流向(万元) | -26971.00 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少3123.6万股，其中基金净增仓4家，主力数没有增加，暂未发现中长期投资价值。
截止2025-12-31，共41家主力机构（基金38家，一般法人3家），持仓量总计16314.57万股，占流通A股11.47%
其中，基金持仓与2025-06-30相比：
增仓：11家 ，增持 32.23万股
减仓：7家 ，减持 48.07万股
新出现在主力名单中：20家 ，持有159.5万股
从主力名单中消失：20家 ，原持有979.06万股
其中，基金持仓与2025-06-30相比：
增仓：11家 ，增持 32.23万股
减仓：7家 ，减持 48.07万股
新出现在主力名单中：20家 ，持有159.5万股
从主力名单中消失：20家 ，原持有979.06万股
消息面诊股
诊断结果：5.5消息面打败了27%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 尔康制药：6月4日获融资买入1558.64万元
2026-06-05 - 尔康制药：5月29日获融资买入2066.69万元
2026-06-01 - 尔康制药：5月28日获融资买入1264.63万元
2026-05-29 - 尔康制药：5月26日获融资买入2509.31万元
2026-05-27 - 尔康制药：5月25日获融资买入3639.04万元
2026-05-26 - 尔康制药：5月21日获融资买入3425.13万元
2026-05-22 - 富祥、尔康跨界碳酸锂救命，药“锂”狂欢还能撑多久？
2026-05-21 - 尔康制药：5月18日获融资买入4086.81万元
2026-05-19 - 【人文尔康】暖心体检护健康 凝心聚力守安全，尔康制
2026-05-18 - 尔康制药：5月15日获融资买入6422.87万元
2026-05-18
消息列表
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-23 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-23 |
| 重大利空 | 业绩预告 | 预计续亏 | 2026-01-29 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-14 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-28 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：4.8行业面打败了71%的股票
化学制药行业最新资金流向
近10日来该行业走势总体向下，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，明显跑输大盘。
[{"date":"2026.06.05","price":"-2.21","value":"0.25"},{"date":"2026.06.04","price":"-0.27","value":"-1.80"},{"date":"2026.06.03","price":"0.73","value":"-1.10"},{"date":"2026.06.02","price":"1.63","value":"-2.06"},{"date":"2026.06.01","price":"-1.51","value":"0.40"},{"date":"2026.05.29","price":"-1.81","value":"0.36"},{"date":"2026.05.28","price":"0.80","value":"-0.71"},{"date":"2026.05.27","price":"-0.88","value":"-1.05"},{"date":"2026.05.26","price":"0.12","value":"-1.43"},{"date":"2026.05.25","price":"1.66","value":"-1.35"},{"date":"2026.05.22","price":"2.30","value":"0.11"},{"date":"2026.05.21","price":"-2.07","value":"-1.67"},{"date":"2026.05.20","price":"0.00","value":"-0.92"},{"date":"2026.05.19","price":"0.26","value":"0.64"},{"date":"2026.05.18","price":"-0.20","value":"-1.49"},{"date":"2026.05.15","price":"-1.17","value":"-0.71"},{"date":"2026.05.14","price":"-2.14","value":"-1.71"},{"date":"2026.05.13","price":"1.67","value":"-0.44"},{"date":"2026.05.12","price":"-0.47","value":"-1.41"},{"date":"2026.05.11","price":"2.16","value":"1.65"},{"date":"2026.05.08","price":"-0.50","value":"0.14"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 纳微科技 | 22.75% | 10.52% | 6.0分 |
| 2 | 东亚药业 | 7.68% | -4.46% | 5.6分 |
| 3 | 科源制药 | 7.57% | 4.57% | 5.3分 |
| 4 | 翰宇药业 | 5.04% | -7.10% | 4.9分 |
| 5 | 科伦药业 | 4.34% | -4.84% | 4.8分 |
| 6 | 新和成 | 0.79% | 8.07% | 5.2分 |
| 8 | 通化金马 | -1.00% | 6.60% | 5.2分 |
| 10 | ST景峰 | -1.66% | -0.14% | 5.1分 |
| 12 | 东诚药业 | -3.83% | -1.88% | 5.1分 |
| 14 | 丽珠集团 | -4.28% | -0.65% | 4.8分 |
| 16 | 贝达药业 | -4.98% | -7.21% | 4.7分 |
| 18 | 共同药业 | -5.46% | -3.46% | 5.3分 |
| 20 | ST人福 | -5.63% | -0.46% | 4.3分 |
| 22 | 华润双鹤 | -5.96% | 0.78% | 5.1分 |
| 24 | 健康元 | -7.90% | -2.84% | 4.6分 |
| 26 | 天宇股份 | -7.97% | 0.00% | 4.6分 |
| 28 | 一品红 | -8.00% | -14.42% | 3.8分 |
| 30 | 海翔药业 | -8.52% | 1.09% | 5.3分 |
| 32 | 奥翔药业 | -8.70% | -2.84% | 4.4分 |
| 34 | 亿帆医药 | -9.14% | -4.20% | 4.4分 |
| 36 | - | -9.48% | -3.84% | 分 |
| 38 | 九典制药 | -9.82% | -3.91% | 4.2分 |
| 40 | 恩华药业 | -10.10% | -4.78% | 4.4分 |
| 42 | 艾力斯 | -10.20% | -5.42% | 5.2分 |
| 44 | 东北制药 | -10.48% | -4.72% | 4.2分 |
| 46 | 天新药业 | -10.60% | -3.51% | 4.5分 |
| 48 | ST惠程 | -10.76% | -2.93% | 4.5分 |
| 50 | 中关村 | -11.06% | -0.48% | 5.2分 |
| 52 | 新华制药 | -11.26% | -4.56% | 4.7分 |
| 54 | - | -11.28% | 0.00% | 分 |
| 56 | 山河药辅 | -11.35% | -1.57% | 4.4分 |
| 58 | 海普瑞 | -11.49% | -3.12% | 4.8分 |
| 60 | 南新制药 | -11.95% | -5.95% | 4.3分 |
| 62 | - | -12.50% | -0.18% | 分 |
| 64 | 千红制药 | -12.68% | -4.27% | 4.3分 |
| 66 | 力生制药 | -12.73% | -3.10% | 4.4分 |
| 68 | 丰原药业 | -13.18% | -1.41% | 4.4分 |
| 70 | 海欣股份 | -13.27% | -8.70% | 4.7分 |
| 72 | 神奇制药 | -13.55% | -2.14% | 5.7分 |
| 74 | 中哲精化 | -13.56% | -7.28% | 5.3分 |
| 76 | 富祥股份 | -13.76% | 3.59% | 4.9分 |
| 78 | 津药药业 | -13.83% | -6.68% | 5.1分 |
| 80 | 易明医药 | -14.40% | -7.86% | 4.5分 |
| 82 | 小方制药 | -14.53% | -2.69% | 4.3分 |
| 84 | 金陵药业 | -14.56% | -1.89% | 4.4分 |
| 86 | 吉贝尔 | -14.75% | -4.34% | 4.3分 |
| 88 | 广济药业 | -14.89% | -3.73% | 4.8分 |
| 90 | - | -15.08% | -1.73% | 分 |
| 92 | 民生健康 | -15.13% | -1.94% | 4.4分 |
| 94 | 汇宇制药 | -15.25% | -3.39% | 4.7分 |
| 96 | 司太立 | -15.42% | -2.29% | 4.7分 |
| 98 | 川宁生物 | -15.48% | -3.71% | 4.6分 |
| 100 | 华北制药 | -15.62% | -2.42% | 4.5分 |
| 102 | 京新药业 | -15.75% | -5.65% | 4.2分 |
| 104 | 泰恩康 | -16.00% | -6.75% | 4.1分 |
| 106 | 凯因科技 | -16.15% | -1.01% | 4.4分 |
| 108 | - | -16.26% | -3.12% | 分 |
| 110 | 北大医药 | -16.45% | -3.72% | 3.9分 |
| 112 | 溢多利 | -16.55% | -5.09% | 5.2分 |
| 114 | 新天地 | -16.61% | -4.74% | 3.8分 |
| 116 | 海森药业 | -16.75% | -5.89% | 3.5分 |
| 118 | 海创药业 | -16.99% | -5.11% | 4.0分 |
| 120 | 奥锐特 | -17.23% | -4.54% | 5.4分 |
| 122 | 本立科技 | -17.62% | -2.78% | 4.6分 |
| 124 | 微芯生物 | -18.21% | -5.89% | 4.5分 |
| 126 | 常山药业 | -18.57% | -9.02% | 3.8分 |
| 128 | 赛托生物 | -19.08% | -1.95% | 5.3分 |
| 130 | 莱美药业 | -19.30% | -5.42% | 4.1分 |
| 132 | 亚虹医药 | -19.88% | -8.61% | 4.8分 |
| 134 | 百利天恒 | -20.12% | -11.02% | 4.0分 |
| 136 | 益方生物 | -20.52% | -9.79% | 4.3分 |
| 138 | 金城医药 | -21.17% | -3.65% | 5.2分 |
| 140 | 盟科药业 | -22.07% | -1.92% | 4.5分 |
| 142 | 兴齐眼药 | -22.65% | -3.88% | 4.1分 |
| 144 | 润都股份 | -23.04% | -5.39% | 4.8分 |
| 146 | 罗欣药业 | -23.54% | -2.33% | 4.7分 |
| 148 | 键凯科技 | -24.33% | -4.91% | 4.6分 |
| 150 | 苑东生物 | -24.85% | -10.63% | 4.4分 |
| 152 | 迪哲医药 | -27.30% | -28.89% | 4.1分 |
| 154 | 博瑞医药 | -29.02% | -8.67% | 4.6分 |
| 156 | 仟源医药 | -30.64% | -10.94% | 4.9分 |
| 158 | 悦康药业 | -36.17% | -22.95% | 3.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 115/218 ， 119/218。
[{"date":"2026-03-31","value":"0.33","vol":"0.43"},{"date":"2025-12-31","value":"-8.96","vol":"-2.03"},{"date":"2025-09-30","value":"0.89","vol":"1.53"},{"date":"2025-06-30","value":"0.84","vol":"1.24"},{"date":"2025-03-31","value":"0.63","vol":"-0.13"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.33 | -8.96 | 0.89 | 0.84 | 0.63 |
| 行业(%) | 0.43 | -2.03 | 1.53 | 1.24 | -0.13 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"28.43","vol":"50.72"},{"date":"2025-12-31","value":"26.44","vol":"49.72"},{"date":"2025-09-30","value":"27.37","vol":"49.60"},{"date":"2025-06-30","value":"27.49","vol":"49.57"},{"date":"2025-03-31","value":"26.14","vol":"49.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
28.43 | 26.44 | 27.37 | 27.49 | 26.14 |
| 行业(%) | 50.72 | 49.72 | 49.60 | 49.57 | 49.06 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 142/218 ， 129/218。
[{"date":"2026-03-31","value":"-30.03","vol":"25.51"},{"date":"2025-12-31","value":"2.29","vol":"38.97"},{"date":"2025-09-30","value":"17.81","vol":"141.63"},{"date":"2025-06-30","value":"9.74","vol":"78.56"},{"date":"2025-03-31","value":"28.19","vol":"0.01"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-30.03 | 2.29 | 17.81 | 9.74 | 28.19 |
| 行业(%) | 25.51 | 38.97 | 141.63 | 78.56 | 0.01 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"-53.37","vol":"47.13"},{"date":"2025-12-31","value":"-1.73","vol":"-26.11"},{"date":"2025-09-30","value":"255.40","vol":"-2.93"},{"date":"2025-06-30","value":"497.36","vol":"59.61"},{"date":"2025-03-31","value":"868.91","vol":"-10.40"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-53.37 | -1.73 | 255.40 | 497.36 | 868.91 |
| 行业(%) | 47.13 | -26.11 | -2.93 | 59.61 | -10.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 134/218 ， 113/218。
[{"date":"2026-03-31","value":"0.05","vol":"0.10"},{"date":"2025-12-31","value":"0.23","vol":"0.41"},{"date":"2025-09-30","value":"0.19","vol":"0.31"},{"date":"2025-06-30","value":"0.13","vol":"0.21"},{"date":"2025-03-31","value":"0.07","vol":"0.10"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.05 | 0.23 | 0.19 | 0.13 | 0.07 |
| 行业(次) | 0.10 | 0.41 | 0.31 | 0.21 | 0.10 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.34","vol":"0.65"},{"date":"2025-12-31","value":"1.54","vol":"2.58"},{"date":"2025-09-30","value":"1.24","vol":"1.93"},{"date":"2025-06-30","value":"0.81","vol":"1.29"},{"date":"2025-03-31","value":"0.41","vol":"0.66"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.34 | 1.54 | 1.24 | 0.81 | 0.41 |
| 行业(次) | 0.65 | 2.58 | 1.93 | 1.29 | 0.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"-4.01","vol":"-2.81"},{"date":"2025-12-31","value":"28.87","vol":"16.49"},{"date":"2025-09-30","value":"51.10","vol":"4.26"},{"date":"2025-06-30","value":"15.23","vol":"2.95"},{"date":"2025-03-31","value":"-1.17","vol":"-26.33"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -4.01 | 28.87 | 51.10 | 15.23 | -1.17 |
| 行业 | -2.81 | 16.49 | 4.26 | 2.95 | -26.33 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.89","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.58","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.89 | - | 0.58 | - |
| 行业 | 0.00 | 1.60 | 0.00 | 1.71 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 11/218 ， 41/218。
[{"date":"2026-03-31","value":"2.09","vol":"3.57"},{"date":"2025-12-31","value":"2.23","vol":"3.31"},{"date":"2025-09-30","value":"2.56","vol":"3.48"},{"date":"2025-06-30","value":"3.03","vol":"3.66"},{"date":"2025-03-31","value":"2.71","vol":"3.57"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
2.09 | 2.23 | 2.56 | 3.03 | 2.71 |
| 行业 | 3.57 | 3.31 | 3.48 | 3.66 | 3.57 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.39","vol":"2.93"},{"date":"2025-12-31","value":"1.49","vol":"2.69"},{"date":"2025-09-30","value":"1.46","vol":"2.73"},{"date":"2025-06-30","value":"1.47","vol":"2.88"},{"date":"2025-03-31","value":"1.50","vol":"2.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
1.39 | 1.49 | 1.46 | 1.47 | 1.50 |
| 行业 | 2.93 | 2.69 | 2.73 | 2.88 | 2.80 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 103/218 ， 108/218。
[{"date":"2026-03-31","value":"20.17","vol":"33.54"},{"date":"2025-12-31","value":"18.25","vol":"34.70"},{"date":"2025-09-30","value":"15.20","vol":"34.06"},{"date":"2025-06-30","value":"12.56","vol":"34.12"},{"date":"2025-03-31","value":"13.85","vol":"34.09"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
20.17 | 18.25 | 15.20 | 12.56 | 13.85 |
| 行业(%) | 33.54 | 34.70 | 34.06 | 34.12 | 34.09 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.25","vol":"9.77"},{"date":"2025-12-31","value":"0.22","vol":"1.76"},{"date":"2025-09-30","value":"0.18","vol":"1.19"},{"date":"2025-06-30","value":"0.14","vol":"0.87"},{"date":"2025-03-31","value":"0.16","vol":"1.44"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.25 | 0.22 | 0.18 | 0.14 | 0.16 |
| 行业(%) | 9.77 | 1.76 | 1.19 | 0.87 | 1.44 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"0.46","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-1.95","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-3.73","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-3.80","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]